Phosphatidylinositol 3-kinase activity is required for the induction of differentiation in C6 glioma cells by panaxydol

Journal of Clinical Neuroscience

Volumn 16, Issue 3, 2009, Pages 444-448

  Hai, Jian ^a   Lin, Qi ^b   Lu, Yang ^b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

C6 glioma cells; Differentiation wortmannin; Panaxydol; PI 3 K

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PANAX NOTOGINSENG EXTRACT; PANAXYDOL; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; DRUG INHIBITION; ENZYME ACTIVITY; GLIOMA CELL; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANALYSIS OF VARIANCE; ANDROSTADIENES; ANIMALS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DIYNES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FATTY ALCOHOLS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; RATS;

EID: 59349118166     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.05.014     Document Type: Article

References (26)

1. Rutka J.T., Hubbard S.L., Fukuyama K., et al. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res 54 (1994) 3267-3272
2. Engelhard H.H., Duncan H.A., and Canto M.D. Molecular characterization of glioblastoma cell differentiation. Neurosurgery 41 (1997) 886-897
3. Shirsat N.V., Kayal J.J., Shaikh S., et al. Growth inhibition and differentiation of C6 glioma cells on treatment with HMBA. Cell Biol Int 25 (2001) 621-627
4. Takanaga H., Yoshitake T., Hara S., et al. cAMP-induced astrocytic differentiation of C6 glioma cells is mediated by autocrine interleukin-6. J Biol Chem 279 (2004) 15441-15447
5. Roymans D., Vissenberg K., De Jonghe C., et al. Phosphatidylinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma. J Neurochem 76 (2001) 610-618
6. Shibasaki F., Fukami K., Fukui Y., et al. Phosphatidylinositol 3-kinase to alpha-actin through the p85 subunit. J Biochem 302 (1994) 551-557
7. Hai J., Lin Q., Lu Y., et al. Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells. Neurol Res 30 (2008) 99-105
8. Wang Z.J., Chen H.Z., and Lu Y. Neurotrophic and neuroprotective effects of panaxynol on PC12 cells. Chin Pharm J 40 (2005) 1073-1076
9. Wang Z.J., Nie B.M., Chen H.Z., et al. Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms. Chem-Biol Interact 159 (2006) 58-64
10. Lin Q., Zhao X., Lu Y., et al. Study on the lipophilic components of Panax notoginseng. Chin Tradit Herbal Drugs 33 (2002) 490-492
11. Hai J., Lin Q., Lu Y., et al. Induction of apoptosis in rat C6 glioma cells by panaxydol. Cell Biol Int 31 (2007) 711-715
12. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol 65 (1983) 55-63
13. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25 (2000) 1439-1451
14. Bello L., Carrabba G., Giussani C., et al. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo. Cancer Res 61 (2001) 7501-7506
15. Lefrancois T., Fages C., Peschanski M., et al. Neuritic outgrowth associated with astroglial phenotypic changes induced by antisense glial fibrillary acidic protein (GFAP) mRNA in injured neuron-astrocyte coculures. J Neurosci 17 (1997) 4121-4128
16. Chen W.J., and Liem R.H.K. Reexpression of glial fibrillary acidic protein rescues the ability of astrocytoma cells to form processes in response to neurons. J Cell Biol 127 (1994) 813-823
17. Parker K.K., Norenberg M.D., and Vernadakis A. Transdifferentiation of C6 glial cells in culture. Science 208 (1980) 179-181
18. 67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J Neurochem 63 (1994) 1218-1225
19. Shepherd P.R., Withers D.J., and Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signaling. J Biochem 333 (1998) 471-490
20. Leevers S.J., Vanhaesebroeck B., and Waterfield M.D. Signaling through phosphoinositide 3-kinases: the lipids take center stage. Curr Opin Cell Biol 11 (1999) 219-225
21. Reddy S.A., Huang J.H., and Liao W.S. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-1 activation. J Biol Chem 272 (1997) 29167-29173
22. Rutka J.T., Hubbard S.L., Fukuyama K., et al. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87 (1997) 420-430
23. Wang J.M., Chao J.R., Chen W., et al. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 19 (1999) 6195-6206
24. Garcia A., Cereghini S., and Sontag E. Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of sp1-responsive promoters. J Biol Chem 275 (2000) 9385-9389
25. Kapeller R., Toker A., Cantley L.C., et al. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin. J Biol Chem 270 (1995) 25985-25991
26. Meter T.E.V., Broaddus W.C., Gash D., et al. Cotreatment with a novel phosphoinositide analogue inhibitor and carmustine enhances chemotherapeutic efficacy by attenuating AKT activity in gliomas. Cancer 107 (2006) 2446-2454